Your browser doesn't support javascript.
loading
Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets.
Corona de la Peña, Norma; Gutiérrez-Aguilar, Manuel; Hernández-Reséndiz, Ileana; Marín-Hernández, Álvaro; Rodríguez-Enríquez, Sara.
Afiliação
  • Corona de la Peña N; Unidad de Investigación en Trombosis, Hemostasia y Aterogénesis, Hospital Carlos McGregor, México City, México.
  • Gutiérrez-Aguilar M; Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Hernández-Reséndiz I; Departamento de Bioquímica, Instituto Nacional de Cardiología, México City, México.
  • Marín-Hernández Á; Departamento de Bioquímica, Instituto Nacional de Cardiología, México City, México.
  • Rodríguez-Enríquez S; Departamento de Bioquímica, Instituto Nacional de Cardiología, México City, México.
PLoS One ; 12(8): e0182374, 2017.
Article em En | MEDLINE | ID: mdl-28817667
ABSTRACT
Thrombin-induced platelet activation requires substantial amounts of ATP. However, the specific contribution of each ATP-generating pathway i.e., oxidative phosphorylation (OxPhos) versus glycolysis and the biochemical mechanisms involved in the thrombin-induced activation of energy metabolism remain unclear. Here we report an integral analysis on the role of both energy pathways in human platelets activated by several agonists, and the signal transducing mechanisms associated with such activation. We found that thrombin, Trap-6, arachidonic acid, collagen, A23187, epinephrine and ADP significantly increased glycolytic flux (3-38 times vs. non-activated platelets) whereas ristocetin was ineffective. OxPhos (33 times) and mitochondrial transmembrane potential (88%) were increased only by thrombin. OxPhos was the main source of ATP in thrombin-activated platelets, whereas in platelets activated by any of the other agonists, glycolysis was the principal ATP supplier. In order to establish the biochemical mechanisms involved in the thrombin-induced OxPhos activation in platelets, several signaling pathways associated with mitochondrial activation were analyzed. Wortmannin and LY294002 (PI3K/Akt pathway inhibitors), ristocetin and heparin (GPIb inhibitors) as well as resveratrol, ATP (calcium-release inhibitors) and PP1 (Tyr-phosphorylation inhibitor) prevented the thrombin-induced platelet activation. These results suggest that thrombin activates OxPhos and glycolysis through GPIb-dependent signaling involving PI3K and Akt activation, calcium mobilization and protein phosphorylation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosforilação Oxidativa / Plaquetas / Trombina / Ativação Plaquetária / Complexo Glicoproteico GPIb-IX de Plaquetas / Glicólise Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosforilação Oxidativa / Plaquetas / Trombina / Ativação Plaquetária / Complexo Glicoproteico GPIb-IX de Plaquetas / Glicólise Idioma: En Ano de publicação: 2017 Tipo de documento: Article